Ionis Pharmaceuticals, INC.
At a glance
Employees500+
In business since2015
HeadquartersCarlsbad, CA
US patents271
SAM.gov UEIP8PVTLSDNNS6
CAGE code09HU6
Incorporated inDE
LEI549300SI4ZGLG0BLUZ92
- DNA-targeted medicines
- serious diseases
- innovation
Named on the company’s own website, read JUL 29, 2026
CareersCareers page — seen SEP 8, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
271 US patents granted 2016–2025, 128 of them in the five years to SEP 2025.
Pharmaceuticals 189Biotechnology 49Organic fine chemistry 28Measurement 3
- Modulating apolipoprotein (A) expressionUS 12,410,430 · granted SEP 9, 2025
- Modulators of HSD17B13 expressionUS 12,409,188 · granted SEP 9, 2025
- Compounds and methods for reducing app expressionUS 12,384,814 · granted AUG 12, 2025
- Compounds and methods for reducing ATXN3 expressionUS 12,350,285 · granted JUL 8, 2025
- Compositions and methods for modulating MECP2 expressionUS 12,343,357 · granted JUL 1, 2025
Newest 5 shown · Granted to Ionis Pharmaceuticals, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Ionis Pharmaceuticals, INC. | Carlsbad | CA | 500+ | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.